Cullinan Therapeutics, Inc. (CGEM)
A forensic read on Cullinan Therapeutics, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
Cullinan Therapeutics, Inc. earns a D (Weak — demands caution) forensic quality grade, and its Altman Z-score is 19.3, placing it in the Safe zone. 1 forensic signal was flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
Key fundamentals
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on Cullinan Therapeutics, Inc.:
No credit card · informational only, not investment advice · see the track record
← Browse all forensic stock analyses
Data from SEC EDGAR public filings · metrics as of Jun 27, 2026. Forensic signals flag probability, not certainty.